A Common Antibiotic Could Prevent, Treat Respiratory Illnesses Including COVID-19: Study
Antibiotic neomycin through the nasal passage triggers a robust interferon-stimulated genes (ISG) line of defense against both SARS-CoV-2 and a highly virulent strain of influenza A virus, the results of an animal study revealed.
Medical Daily ·